Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

Overview of attention for article published in Breast Cancer Research, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

news: 3 news outlets

twitter: 1 tweeter

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 16 Mendeley

Summary News Twitter Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Oncotarget: Phase 1 study of Z-Endoxifen in patients with solid tumors | Scienmag: Latest Science and Health News

ScienMag, 25 Mar 2021

The Oncotarget article provides evidence that antitumor activity and prolonged stable disease are achieved with Z-endoxifen…

Oncotarget: Phase 1 study of Z-Endoxifen in patients with solid tumors

Bioengineer.org, 25 Mar 2021

The Oncotarget article provides evidence that antitumor activity and prolonged stable disease are achieved with Z-endoxifen…

Oncotarget: Phase 1 study of Z-Endoxifen in patients with solid tumors

EurekAlert!, 25 Mar 2021

Oncotarget published "Phase 1 study of Z-Endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.